International study of health care organization and financing: development of renal replacement therapy in Germany

Int J Health Care Finance Econ. 2007 Sep;7(2-3):185-200. doi: 10.1007/s10754-007-9020-0.

Abstract

The German health system represents the case of a global budget with negotiated fees and competing medical insurance companies. Physicians in private practice and non-profit dialysis provider associations provide most dialysis therapy. End-stage renal disease (ESRD) modalities are well integrated into the overall health care system. Dialysis therapy, independent of the mode of treatment, is reimbursed at a weekly flat rate. Mandatory health insurance covers health expenses, including those related to ESRD, for more than 90% of the population. Both employees and employers contribute to the premium for this insurance. Private medical insurance covers the remainder of the population. Access to treatment, including dialysis therapy, is uniformly available.

MeSH terms

  • Dialysis / economics
  • Germany / epidemiology
  • Health Expenditures
  • Health Services / economics
  • Health Services / statistics & numerical data
  • Health Services Accessibility
  • Humans
  • Kidney Failure, Chronic / economics*
  • Kidney Failure, Chronic / epidemiology
  • Kidney Failure, Chronic / therapy*
  • Kidney Transplantation / economics
  • National Health Programs / economics
  • National Health Programs / organization & administration*
  • Reimbursement Mechanisms / organization & administration